SANTA MONICA, Calif., Dec. 30, 2004 (PRIMEZONE) -- HeartSTAT Technology, Inc. (Pink Sheets:HSTA) ("HeartSTAT") announces that it has taken the first step in its journey to move its listing from the OTC Pink Sheets to the OTCBB markets in 2005. The company filed its initial Form 10-SB with the Securities and Exchange Commission on October 20, 2004. HeartSTAT is now required to now fully comply and report according to the Securities and Exchange Act of 1934. HeartSTAT's first annual Form 10K for the fiscal year ending December 31, 2004 is due by March 31, 2005.
Company CEO, Jim Hudson commented: "We are currently responding to all the SEC comments on our initial Form 10-SB filing and once all these comments are satisfied then HeartSTAT plans to seek to have its common shares quoted on the OCTBB."
About HeartSTAT:
HeartSTAT has developed and patented the HeartSTAT CNBP/BF technology, which is believed to be the first, safe non-invasive patient monitoring system that will diagnose pre-symptomatic heart disease and shock in its early stages.
Cardiovascular disease is the number one cause of death in the United States; shock has an annual mortality of 300,000, almost equal to the total number of cancer deaths. HeartSTAT's technology detects heart disease before it becomes symptomatic and septic shock before the traditional vital signs crash, thus the creation of "The Fifth Vital Sign". For more information on this technology and company please go to www.HeartSTAT.com
Statements in this release are "forward-looking statements". Investors are cautioned that such forward-looking statements involve risk and uncertainties including, without limitation, acceptance of the company's products, significant levels of competition for the company and dependence on the performance of the management of the company.